论文部分内容阅读
目的 探讨米非司酮配伍米索前列醇低剂量用于中期引产的疗效。方法 2 3例采用米非司酮配伍米索前列醇 ,米非司酮 15 0mg分次口服 ,米索服用时间为间隔 1h 2 0 0 μg口服 ,服用 2次后根据宫缩情况选择用药时间 ;36例采用利凡诺尔羊膜腔穿刺术。结果 两组引产成功率差异无显著意义 ,刮宫率双米组明显少于利凡诺组 ,且双米组住院费用低于利凡诺组。结论 米非司酮配伍米索前列醇引产使用方便、出血少、刮宫率低、适用范围广 ,为中期妊娠提供了一个安全、可靠的引产方法。
Objective To investigate the efficacy of mifepristone with misoprostol at low dose for mid-term induction of labor. Twenty-three cases were treated with mifepristone and misoprostol, mifepristone 150 mg sub-orally, with the dose of misoprostol administered orally 1 h 200 ug once. After taking 2 times, the medication duration was chosen according to the contractions. Thirty-six patients received rivanol amniocentesis. Results There was no significant difference in the success rate of induction of labor between the two groups. The curettage rate in the two-meter group was significantly lower than that in the rivanol group, and the hospitalization cost in the two-meter group was lower than that of the rivanol group. Conclusion Mifepristone with misoprostol induction of labor is easy to use, less bleeding, curettage rate is low, wide range of applications, providing a safe and reliable method of induction of labor during pregnancy.